BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kerr L, Cadegiani FA, Baldi F, Lobo RB, Assagra WLO, Proença FC, Kory P, Hibberd JA, Chamie-quintero JJ. Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching. Cureus. [DOI: 10.7759/cureus.21272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Kerr L, Baldi F, Lobo R, Assagra WL, Proença FC, Chamie JJ, Hibberd JA, Kory P, Cadegiani FA. Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects. Cureus 2022. [DOI: 10.7759/cureus.28624] [Reference Citation Analysis]
2 Awad H, Hassan B, Dweek S, Aboelata Y, Rawas-qalaji M, Ahmed IS. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022;15:1068. [DOI: 10.3390/ph15091068] [Reference Citation Analysis]
3 Hazan S. Microbiome-Based Hypothesis on Ivermectin’s Mechanism in COVID-19: Ivermectin Feeds Bifidobacteria to Boost Immunity. Front Microbiol 2022;13:952321. [DOI: 10.3389/fmicb.2022.952321] [Reference Citation Analysis]
4 Ahen F. Community-Level Health Interventions are Crucial in the Post-COVID-19 Era: Lessons from Africa’s Proactive Public Health Policy Interventions. Humanist Manag J 2022. [DOI: 10.1007/s41463-022-00127-3] [Reference Citation Analysis]